Markus Müschen

25PUBLICATIONS

150CO-AUTHORS

Haematological tumoursMolecular targetsCancer geneticsCancer cell biologyGene expression (incl. microarray and other genome-wide approaches)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jul 01, 2026

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

|Feb 10, 2026

Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.

Jaewoong Lee, Ruifeng Sun, Kohei Kume

|Jan 08, 2026

Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia.

Kadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson

|Sep 04, 2024

Tuning Responses to Polatuzumab Vedotin in B-cell Lymphoma.

Etienne Leveille, Shalin Kothari, Kadriye N Cosgun

|Feb 23, 2024

Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery.

Anthony K N Chan, Li Han, Christopher D Delaney

|Sep 18, 2023

PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.

Tim Wartewig, Jay Daniels, Miriam Schulz

Pageof 5

Frequent Collaborators

Jianjun Chen

Chun-Wei Chen

Kohei Kume

Nagarajan Vaidehi

Mark E Robinson

Matthew A Nix

Mohamed A Ahmed

Arun P Wiita

Ye Chen

Liang Xu

Frequent Collaborators

Jianjun Chen

Chun-Wei Chen

Kohei Kume

Nagarajan Vaidehi